Psychostimulant medication approved in the United States for treatment of narcolepsy (marketed as Provigil); investigational for other uses. Modafinil is less likely to cause jitteriness, anxiety, excess locomotor activity, or a hypersomnolent 'rebound effect' than the amphetamines.
Related categories 2
Information sheet covering proper use, drug interactions, contraindications, and side effects.
Information about this mood-brightening and memory-enhancing psychostimulant which enhances wakefulness and vigilance. Discusses mode of action and uses in treating narcolepsy, as well as experimental uses.
Cephalon corporate site for the company's branded version of modafinil, sold as a wake-promoting medication for treating narcolepsy. Information for U.S. patients and physicians.
Last update:October 18, 2016 at 3:38:32 UTC